These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3669276)

  • 1. Study of immunological mechanism in dilated cardiomyopathy.
    Yamakawa K; Fukuta S; Yoshinaga T; Umemoto S; Itagaki T; Kusukawa R
    Jpn Circ J; 1987 Jun; 51(6):665-75. PubMed ID: 3669276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on lymphocyte subsets and NK cell function in patients with dilated cardiomyopathy.
    Yamakawa K; Fukuta S; Yoshinaga T; Umemoto S; Itagaki T; Kusukawa R
    Jpn Circ J; 1986 Dec; 50(12):1259-63. PubMed ID: 2950255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating anti-heart antibodies in heart diseases detected using an immunofluorescent technique.
    Yamakawa K; Fukuta S; Kimura Y; Hayashi Y; Kusukawa R
    Jpn Circ J; 1983 Oct; 47(10):1173-8. PubMed ID: 6195361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immunity in cardiomyopathy.
    Lowry PJ; Thompson RA; Littler WA
    Br Heart J; 1983 Oct; 50(4):390-4. PubMed ID: 6354229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dilated cardiomyopathy with special reference to humoral immunity.
    Fukuta S; Yoshinaga T; Yamakawa K; Kimura Y; Kusukawa R
    Jpn Circ J; 1992 Oct; 56(10):1073-80. PubMed ID: 1433822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunophenotypic and functional characterization of peripheral blood mononuclear cell populations in patients with dilated cardiomyopathy.
    Grzelak I; Lukomska B; Sadowska-Szablisty D; Olszewski WL; Dabrowski M; Ruzyłło W
    Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):33-40. PubMed ID: 1839493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological study of heart diseases with special reference to the cytotoxicity of the heterophile antibody against cultured myocardial cells.
    Fukuta S; Yamakawa K; Hayashi Y; Iwamoto S; Umemoto S; Kusukawa R; Wada K
    Jpn Circ J; 1984 Dec; 48(12):1354-7. PubMed ID: 6392595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement-mediated cytotoxic activity of anti-heart antibodies present in the sera of patients with dilated cardiomyopathy.
    Latif N; Smith J; Dunn MJ; Yacoub MH; Rose ML
    Autoimmunity; 1994; 19(2):99-104. PubMed ID: 7772707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional abnormalities of circulating natural killer cell subpopulations in patients with dilated cardiomyopathy.
    Kanda T; Yokoyama T; Suzuki T; Murata K
    Tohoku J Exp Med; 1992 Nov; 168(3):529-37. PubMed ID: 1284796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular immune response in patients with dilated cardiomyopathy.
    Dabrowski M; Grzelak I; Ruzyłło V; Lukomska B; Sadowska-Szablisty D; Olszewski WL
    Cor Vasa; 1989; 31(6):476-84. PubMed ID: 2637101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory dilated cardiomyopathy (DCMI).
    Maisch B; Richter A; Sandmöller A; Portig I; Pankuweit S;
    Herz; 2005 Sep; 30(6):535-44. PubMed ID: 16170686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte subsets in patients with dilated cardiomyopathy and perimyocarditis.
    Takamoto T; Hori Y; Yokoyama MM; Koga Y; Toshima H
    J Clin Lab Immunol; 1986 Mar; 19(3):113-6. PubMed ID: 3754903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunoregulatory lymphocyte subpopulations in patients with dilated and hypertrophic cardiomyopathies].
    Chumburidze VB; Iurenev AP; Tabazari DZ; Dzidziguri LM; Krukovskaia ZV
    Ter Arkh; 1986; 58(10):59-62. PubMed ID: 2879362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The pathogenesis of dilated cardiomyopathy: current progress].
    Mestroni L; Giacca M; Severini GM; Camerini F
    G Ital Cardiol; 1992 Jan; 22(1):53-62. PubMed ID: 1624069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral immunity and lymphocyte subpopulations in patients with dilated cardiomyopathy.
    Franceschini R; Messina V; Petillo A; Corazza M; Bottaro L; Gianrossi R
    Int J Cardiol; 1985 Jun; 8(2):113-23. PubMed ID: 3874172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of costimulatory molecules B7-1, B7-2, and CD40 in the heart of patients with acute myocarditis and dilated cardiomyopathy.
    Seko Y; Takahashi N; Ishiyama S; Nishikawa T; Kasajima T; Hiroe M; Suzuki S; Ishiwata S; Kawai S; Azuma M; Yagita H; Okumura K; Yazaki Y
    Circulation; 1998 Feb; 97(7):637-9. PubMed ID: 9495297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of pathological parameters of endomyocardial biopsy in clinical outcome of patients of dilated cardiomyopathy--II. Value of cardiac immune complexes and heart reactive antibodies.
    Dawson L; Talwar KK; Chopra P
    Indian Heart J; 1991; 43(6):421-5. PubMed ID: 1823888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Humoral immunity indices of patients with dilated cardiomyopathy and rheumatism].
    Gritsiuk AI; Amosova EN; Sidorova LL; Fedorich VN; Golubchuk NV
    Vrach Delo; 1988 Mar; (3):61-3. PubMed ID: 3394303
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiac myosin autoantibodies and acute rejection after heart transplantation in patients with dilated cardiomyopathy.
    Warraich RS; Pomerance A; Stanley A; Banner NR; Dunn MJ; Yacoub MH
    Transplantation; 2000 Apr; 69(8):1609-17. PubMed ID: 10836370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-specific immunoadsorption in patients with dilated cardiomyopathy: mechanisms and clinical effects.
    Felix SB; Staudt A
    Int J Cardiol; 2006 Sep; 112(1):30-3. PubMed ID: 16860418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.